PPI Lawsuits are still awaiting...
PPI Lawsuits are still awaiting...
Introduction
As the PPI case filings seem to have significantly increased, the Judicial Panel on Multidistrict Litigation (JPML) took a decision to hear the argument of PPI litigations on July 27, 2017, under a new motion to create centralization of cases under MDL, which was earlier rejected by U.S. District Judge Sarah Vance as the cases seemed too complicated with so many generics and manufacturers connected with PPIs. This hearing may bring out a positive turn to PPI litigation.
Latest News
title demo for news
Zantac Settles 4,000 Lawsuits in U.S. Courts
Sanofi has announced a settlement agreement regarding approximately 4,000 Zantac cancer lawsuits filed in state courts across the country.
…Valsartan Recall Lawsuit Set for Trial
Years after the initiation of Valsartan recalls, the U.S. District Judge overseeing lawsuits filed by individuals harmed by tainted versions of…